InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Hashim Mir, Directeur Scientifique. Director active across 1 company, notably Rani Therapeutics Holdings, Inc.. Aggregated, 5 reports have been recorded. Activity tracked since 9 September 2021. The latest transaction was filed on 27 March 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Mir Hashim is the Chief Scientific Officer at Rani Therapeutics Holdings, Inc. He is responsible for leading the company's research and development efforts. With expertise in scientific fields, he plays a crucial role in innovation and the development of new therapies. Mir Hashim is committed to advancing the company's mission by providing cutting-edge therapeutic solutions.